Kidney cell therapy shows promise for diabetic patients
Disease control
Completed
This study tested a treatment called REACT (rilparencel) for people with type 1 or 2 diabetes who also have chronic kidney disease. The treatment uses a person's own kidney cells to try to slow down kidney damage. 53 adults took part, and the study looked at safety and whether it…
Phase: PHASE2 • Sponsor: Prokidney • Aim: Disease control
Last updated May 15, 2026 11:55 UTC